tyrosine has been researched along with Muscle Weakness in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Deguchi, K; Deguchi, S; Hishikawa, N; Kono, S; Matsuzono, K; Motomura, M; Nakano, Y; Ohta, K; Ota, Y; Sato, K; Tanabe, K; Yamashita, T | 1 |
| Ahlstrand, E; Ajeganova, S; Aresh, B; Beard, N; Cheng, AJ; Friedman, R; Gustafsson, T; Karlsson, BC; Karlsson, R; Kenne, E; Lanner, JT; Lilja, M; Lundberg, TR; Möller, KÄ; Olsson, K; Persson, M; Rassier, DE; Rullman, E; Sandor, K; Steinz, MM; Svensson, CI; Tavi, P; Yamada, T | 1 |
| Barreiro, E; Chacon-Cabrera, A; de Kier Joffé, ED; Diament, MJ; Fermoselle, C; Mateu-Jimenez, M; Sandri, M; Urtreger, AJ | 1 |
| Alcantara, RR; Baltgalvis, KA; Chen, Y; Claypool, MD; Creger, DP; Ding, R; Friera, AM; Gelman, MS; Godinez, GL; Gururaja, T; Hansen, D; Ho, MS; Kinoshita, T; Kinsella, TM; Kwon, OS; Lang, W; Li, W; Masuda, ES; McCaughey, KM; McLaughlin, JR; Nguyen, HN; Payan, DG; Powers, SK; Romero, JM; Singh, BK; Singh, R; Smith, IJ; Smuder, AJ; Sollanek, KJ; Taylor, VC; White, KA; Wiggs, MP; Yam, GC; Yung, SL | 1 |
| Callahan, LA; Supinski, GS; Vanags, J | 1 |
| Bernabei, C; Bragato, C; Chiari, A; Gellera, C; Georgoulopoulou, E; Mandrioli, J; Sola, P | 1 |
| Domazetovska, A; Gunning, PW; Hardeman, EC; Hook, JW; Joya, JE; Kee, AJ; Kettle, E; Lemckert, FA; Mitchell, CA; Nguyen, MA; North, KN; Robinson, PJ; Valova, VA; Yang, N | 1 |
7 other study(ies) available for tyrosine and Muscle Weakness
| Article | Year |
|---|---|
Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy.
Topics: Adult; Ambulatory Care; Autoantibodies; Deglutition Disorders; Humans; Immunoglobulins, Intravenous; Male; Muscle Weakness; Myasthenia Gravis; Plasma Exchange; Plasmapheresis; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Tyrosine | 2018 |
Oxidative hotspots on actin promote skeletal muscle weakness in rheumatoid arthritis.
Topics: Actins; Animals; Arthritis, Rheumatoid; Disease Models, Animal; Female; Humans; Malondialdehyde; Mice; Mice, Inbred C57BL; Molecular Dynamics Simulation; Muscle Contraction; Muscle Weakness; Muscle, Skeletal; Myosins; Oxidative Stress; Polymerization; Protein Processing, Post-Translational; Tyrosine | 2019 |
Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
Topics: Animals; Autophagy; Boronic Acids; Bortezomib; Butadienes; Cachexia; Cell Line, Tumor; Inflammation; Lung Neoplasms; Mice; Mice, Inbred BALB C; Muscle Contraction; Muscle Proteins; Muscle Weakness; Muscle, Skeletal; NF-kappa B; Nitriles; Oxidation-Reduction; Proteolysis; Pyrazines; Signal Transduction; Sulfasalazine; Tyrosine; Weight Gain | 2014 |
Inhibition of Janus kinase signaling during controlled mechanical ventilation prevents ventilation-induced diaphragm dysfunction.
Topics: Animals; Diaphragm; Interleukin-6; Janus Kinases; Male; Mitochondria; Muscle Weakness; Muscular Atrophy; Oxidative Stress; Phosphorylation; Proteolysis; Rats; Rats, Sprague-Dawley; Respiration, Artificial; Serine; Signal Transduction; STAT3 Transcription Factor; Tyrosine | 2014 |
Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.
Topics: Animals; Atrophy; Boronic Acids; Bortezomib; Caspase 3; Cysteine Proteinase Inhibitors; Diaphragm; Endotoxemia; Enzyme Activation; Leupeptins; Male; Muscle Contraction; Muscle Weakness; Oligopeptides; Organ Size; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Rats; Rats, Sprague-Dawley; Sepsis; Tyrosine | 2009 |
A novel SOD1 mutation in a young amyotrophic lateral sclerosis patient with a very slowly progressive clinical course.
Topics: Adult; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; Atrophy; Disease Progression; Electromyography; Humans; Leg; Male; Muscle Weakness; Muscle, Skeletal; Mutation; Peripheral Nerves; Phenotype; Superoxide Dismutase; Superoxide Dismutase-1; Time Factors; Tyrosine | 2010 |
Hypertrophy and dietary tyrosine ameliorate the phenotypes of a mouse model of severe nemaline myopathy.
Topics: Animals; Disease Models, Animal; Hand Strength; Hypertrophy; Mice; Mice, Transgenic; Muscle Contraction; Muscle Weakness; Muscle, Skeletal; Mutation; Myopathies, Nemaline; Phenotype; Tyrosine | 2011 |